Camarda Financial Advisors LLC now owns 2,508 shares of the company's stock worth $182,000 after purchasing an additional 391 shares in the last quarter. Jefferies Group lifted their price objective on shares of AbbVie from $107.00 to $115.00 and gave the company a buy rating in a research note on Monday, October 16th. The stock decreased 0.26% or $0.12 during the last trading session, reaching $44.5. AbbVie Inc. (NYSE:ABBV) has risen 10.63% since December 5, 2016 and is uptrending. It has underperformed by 6.07% the S&P500. Aristotle Capital Management LLC now owns 4,526,623 shares of the company's stock worth $294,954,000 after acquiring an additional 154,719 shares during the period.
The company reported its last earnings Actual EPS of $1.41/share. Barrett Asset Mngmt Limited has 2.07% invested in AbbVie Inc. (ABBV) traded up $0.19 during trading hours on Tuesday, reaching $95.41. About 1.58 million shares traded. It is down 0.00% since December 5, 2016 and is. It has outperformed by 35.20% the S&P500. What Now?" on December 04, 2017, also Seekingalpha.com with their article: "Dividend Aristocrats In Focus Part 45: "AbbVie" published on November 22, 2017, Seekingalpha.com published: "Premarket analyst action - healthcare" on November 28, 2017. Tdam Usa holds 462,029 shares or 1.72% of its portfolio. (NYSE:ABBV) has "Buy" rating given on Monday, December 7 by Jefferies. Therefore 52% are positive. Bradley Foster & Sargent Ct reported 0.48% in AbbVie Inc. Deutsche Bank maintained the stock with "Hold" rating in Thursday, June 16 report. (NYSE:ABBV) earned "Hold" rating by BMO Capital Markets on Sunday, July 30. The company was upgraded on Wednesday, September 2 by UBS. Finally, Cowen reiterated a "hold" rating and set a $95.00 price objective (up from $70.00) on shares of AbbVie in a research note on Monday, September 11th. RBC Capital Markets maintained the stock with "Sector Perform" rating in Tuesday, September 8 report. The company was downgraded on Monday, June 6 by Cowen & Co. BidaskClub raised shares of AbbVie from a buy rating to a strong-buy rating in a research report on Saturday, November 11th. RBC Capital Markets has "Outperform" rating and $28 target. The firm earned "Underperform" rating on Thursday, December 10 by BNP Paribas.
Legal & General Group Plc increased its position in shares of AbbVie by 1.7% during the second quarter. Its up 0.12, from 0.95 in 2017Q1. South Dakota Invest Council accumulated 0.28% or 183,603 shares. Edgar Lomax Company Va owns 145,111 shares for 0.72% of their portfolio. Reliance Comm Of Delaware has 10,153 shares for 0.05% of their portfolio.
According to the Recommendation Trends of the stock polled by Finviz, the company has a consensus recommendation of 2.3 out of the scale from 1 to 5, where 1 stands for Buy and 5 means Sell. Blue Cap accumulated 15,178 shares. Aqr Management Llc accumulated 0% or 60,352 shares.
The company last reported its quarterly results on Oct 27 BMO. Tiedemann Wealth Management Lc has 21,881 shares. Farallon Limited Liability Co has 835,000 shares. Moreover, Riverhead Ltd Liability Corporation has 0.02% invested in Olin Corporation (NYSE:OLN). (NYSE:ABBV) for 63,716 shares. Page Arthur B, a Massachusetts-based fund reported 7,425 shares. It is positive, as 55 investors sold ABBV shares while 581 reduced holdings.
Granite Investment Advisors LLC Trims Holdings in Johnson & Johnson (NYSE:JNJ)
Town Country Bancorp Trust Dba First Bankers Trust holds 2.48% or 34,829 shares. 30 funds opened positions while 55 raised stakes. Systematic Financial Management Limited Partnership invested 0.15% of its portfolio in Johnson & Johnson (NYSE: JNJ ).
A number of institutional investors and hedge funds have recently made changes to their positions in ABBV. Clean Yield Gru stated it has 0.29% in AbbVie Inc.
AbbVie Inc. (ABBV) has a Return on Assets of 9.9 percent, Return on Investment of 18 percent and a Return on Equity of 119.1 percent. (NYSE:ABBV). 490,948 are owned by Mackenzie Financial. Iberiabank Corp reported 81,633 shares stake. Foyston Gordon And Payne has 12,275 shares for 0.19% of their portfolio. Pinebridge Investments Lp has invested 0.05% in AbbVie Inc. Investors of record on Friday, January 12th will be paid a $0.71 dividend. Umb National Bank N A Mo invested 0.31% in AbbVie Inc. While talking about Performance of the Stock, AbbVie Inc. now has a Weekly performance of 1.69%, monthly performance percentage is 4.2 percent, Quarterly performance is 27.71 percent, 6 months performance shows a percent value of 42.68% and Yearly Performance is 62.81 percent. Alphabet Inc was raised too. The firm holds 100% interest in the Gold Springs gold-silver project consisting of 961 unpatented lode claims, 13 patented lode claims, 4 the State of Utah mineral leases, and 1 surface real estate deed parcel and right-of-way covering approximately 7,807 hectares located in Western Iron, Utah, and Eastern Lincoln Counties, Nevada. Following the completion of the sale, the chairman now directly owns 492,030 shares in the company, valued at $46,255,740.30. Over the last quarter, insiders sold 277,125 shares of company stock worth $25,891,756.
Analysts await Sanofi (NYSE:SNY) to report earnings on February, 14. During the same period in the previous year, the firm posted $1.21 earnings per share. (NYSE:ABBV) showed a growth of 16.83 Percent per annum. Culbertson A N & Communication reported 1.98% of its portfolio in AbbVie Inc. It also reduced its holding in Natus Medical Inc Del (NASDAQ:BABY) by 177,584 shares in the quarter, leaving it with 933,348 shares, and cut its stake in Ameriprise Finl Inc (NYSE:AMP).
Sell side analysts plays vital role in buying and selling a stock where 3 analysts rated AbbVie Inc.
In other AbbVie news, VP Robert A. Michael sold 6,699 shares of the business's stock in a transaction dated Thursday, September 28th.